Therma Bright Inc (TSX-V:THRM, OTC:TBRIF) has modified its acquisition agreement with August Therapeutics and Ketiko Bio Corp, aiming to acquire a 25% stake in InStatin, Inc. and InVixa, Inc. The amended deal involves issuing a total of 55 million shares to the vendors and obtaining options for additional shares in InStatin, contingent on cash payments.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com